Filing Details
- Accession Number:
- 0001209191-17-061613
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-17 18:42:46
- Reporting Period:
- 2017-11-15
- Accepted Time:
- 2017-11-17 18:42:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1435049 | Aduro Biotech Inc. | ADRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1465994 | Jennifer Lew | C/O Aduro Biotech, Inc. 740 Heinz Avenue Berkeley CA 94710 | Sr. Vice President Of Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-15 | 6,600 | $0.82 | 68,938 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-15 | 6,600 | $8.95 | 62,338 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-11-15 | 6,600 | $0.00 | 6,600 | $0.82 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
57,309 | 2023-11-26 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2017.
- The shares subject to the Option are fully vested and immediately exercisable.